Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic.

Although there was still an increase in NfL in the 8-week arm at the same time as in the 4-week arm, it was of a lower magnitude that did not reach statistical significance and remained only 10% above baseline at the 15-month timepoint.

also in 111,027 other papers